News
RCM
12.47
-2.43%
-0.31
R1 RCM, Health Catalyst downgraded as KeyBanc reviews health-tech space
R1 RCM, Health Catalyst downgraded as KeyBanc Capital Markets downgrades the stocks ahead of Q1 earnings. The firm upgraded GoodRx Holdings and Certara ahead of the healthcare IT space. The analyst cited the recent cybersecurity incident at UnitedHealth's Change Healthcare unit.
Seeking Alpha · 2d ago
R1 RCM Price Target Maintained With a $20.00/Share by Cantor Fitzgerald
Dow Jones · 2d ago
Cantor Fitzgerald Reiterates Overweight on R1 RCM, Maintains $20 Price Target
Benzinga · 2d ago
R1 RCM INC <RCM.O>: KEYBANC CUTS TO SECTOR WEIGHT FROM OVERWEIGHT
Reuters · 2d ago
R1 RCM Cut to Sector Weight From Overweight by Keybanc
Dow Jones · 3d ago
Keybanc Downgrades R1 RCM to Sector Weight
Benzinga · 3d ago
Analysts Anticipate FXH Will Reach $123
NASDAQ · 4d ago
Weekly Report: what happened at RCM last week (0401-0405)?
Weekly Report · 4d ago
The Latest Analyst Ratings For R1 RCM
R1 RCM (NASDAQ:RCM) underwent analysis by 13 analysts in the last quarter. The company has an average price target of $16.31, with a 12-month average of $14.00. R1 RCm is a provider of technology-driven solutions to healthcare providers. The firm has a revenue growth rate of 7.84%.
Benzinga · 04/05 17:00
R1 RCM Is Maintained at Buy by Guggenheim
Dow Jones · 04/05 14:43
R1 RCM Price Target Cut to $15.00/Share From $17.00 by Guggenheim
Dow Jones · 04/05 14:43
Guggenheim Maintains Buy on R1 RCM, Lowers Price Target to $15
Benzinga · 04/05 14:34
R1 RCM INC <RCM.O>: GUGGENHEIM CUTS TARGET PRICE TO $15 FROM $17
Reuters · 04/05 10:21
R1 RCM TO RELEASE FIRST QUARTER 2024 RESULTS ON MAY 8, 2024
Reuters · 04/01 21:00
R1 RCM Is Maintained at Hold by Truist Securities
Dow Jones · 04/01 13:07
R1 RCM Price Target Maintained With a $16.00/Share by Truist Securities
Dow Jones · 04/01 13:07
Truist Financial Reaffirms Their Hold Rating on R1 RCM (RCM)
TipRanks · 04/01 11:19
Weekly Report: what happened at RCM last week (0325-0329)?
Weekly Report · 04/01 09:29
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report
R1 RCM Inc. Has released its 2023 Environmental, Social and Governance (ESG) report. The report details the company's commitment to improving access to healthcare. The company's ESG program aims to bring responsible global citizenship to life through its program.
Barchart · 03/27 07:00
Morgan Stanley Reiterates Overweight on R1 RCM, Maintains $17 Price Target
Benzinga · 03/26 16:16
More
Webull provides a variety of real-time RCM stock news. You can receive the latest news about R1 Rcm Inc through multiple platforms. This information may help you make smarter investment decisions.
About RCM
R1 RCM Inc. is a provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups. The Company’s scalable operating models seamlessly complement a healthcare organization’s infrastructure, driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. The Company delivers solutions to customers through technology, intellectual property (IP), global scale, and operational excellence. Its Intelligent Automation modernizes processes, removes friction, and simplifies revenue cycle management (RCM). Its use of artificial intelligence (AI) in its platform depends on the availability and pricing of equipment and technical infrastructure from third parties, including Microsoft Azure. It serves over 3,700 hospitals, including 93 of the top 100 health systems, and over 30,000 physicians.